Joel L. Pomerantz
- Immunology top 2%
- Immune Cell Function and Interaction 14
- Immune Response and Inflammation 5
- T-cell and B-cell Immunology 5
- Toxin Mechanisms and Immunotoxins 5
- Immunodeficiency and Autoimmune Disorders 4
- Cancer Research top 2%
- NF-κB Signaling Pathways 19
- Virology top 5%
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways 4
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions 7
- Co-authors
- David BaltimorePhillip A. SharpCarl O. PaboThomas M. KristieRyan R. McCullyKaren SommerDavid J. RawlingsAshok D. Bandaranayake
- Cited by
- ImmunologyCancer ResearchVirology
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (3 papers)Journal of Biological Chemistry (7 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Joel L. Pomerantz
40 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 111
- Immunology 1.4k
- Cancer Research 984
- Virology 89
- Molecular Biology 1.2k
- Oncology 461
Countries citing papers authored by Joel L. Pomerantz
This map shows the geographic impact of Joel L. Pomerantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel L. Pomerantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel L. Pomerantz more than expected).
Fields of papers citing papers by Joel L. Pomerantz
This network shows the impact of papers produced by Joel L. Pomerantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel L. Pomerantz. The network helps show where Joel L. Pomerantz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joel L. Pomerantz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 9 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 25 | |
| 6 | 2020 | 3 | |
| 7 | 2019 | 13 | |
| 8 | 2018 | 60 | |
| 9 | 2017 | 65 | |
| 10 | 2016 | 28 | |
| 11 | 2010 | 39 | |
| 12 | 2010 | 2 | |
| 13 | 2009 | 41 | |
| 14 | 2008 | 54 | |
| 15 | 2005 | 276 | |
| 16 | The prisoner's dilemma and predator-prey coevolution | 2002 | 2 |
| 17 | 2002 | 181 | |
| 18 | 2002 | 342 | |
| 19 | 1999 | 499 | |
| 20 | 1994 | 51 |
About Joel L. Pomerantz
Joel L. Pomerantz is a scholar working on Immunology, Cancer Research and Business and International Management, having authored 41 papers that have together received 2.7k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (19 papers), Immune Cell Function and Interaction (14 papers), Cytokine Signaling Pathways and Interactions (7 papers), Immune Response and Inflammation (5 papers), T-cell and B-cell Immunology (5 papers), Toxin Mechanisms and Immunotoxins (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Immunology (1.4k citations), Cancer Research (984 citations) and Virology (89 citations). Joel L. Pomerantz has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include David Baltimore, Phillip A. Sharp, Carl O. Pabo, Thomas M. Kristie, Ryan R. McCully, Karen Sommer, David J. Rawlings, Ashok D. Bandaranayake, Beichu Guo and Miguel E. Moreno‐García. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.